Type 2 diabetes mellitus with hypertension at primary healthcare level in Malaysia: Are they managed according to guidelines?

Singapore Medical Journal

Volumn 46, Issue 3, 2005, Pages 127-131

  Chan, Giin Cherng ^a  

^a Peringgit Community Polyclinic   (Malaysia)

Author keywords

Clinical practice guidelines; Diabetes mellitus; Hypertension; Primary healthcare

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; METOPROLOL; NIFEDIPINE; PRAZOSIN;

ADULT; AGED; ANALYZER; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CHINESE; COMORBIDITY; ETHNIC GROUP; FEMALE; HUMAN; HYPERTENSION; INDIAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MICROALBUMINURIA; MONOTHERAPY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY HEALTH CARE; SPHYGMOMANOMETER;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; MALAYSIA; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PREVALENCE; PRIMARY HEALTH CARE;

EID: 15244355524     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Arauz-Pacheco C, Parrott MA, Raskin P. American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2003; 26 Suppl 1:S80-2.
2. Public Health Institute, Ministry of Health. National health and morbidity survey II 1996 Malaysia. Malaysia: Ministry of Health, 1997.
3. George LB, Mark W, Lance D, William JE, Murray E, Robert T, Preserving renal function in adult with hypertension and diabetes: A consensus approach. Am J Kidney Dis 2000; 36:646-61.
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. UK Prospective Diabetes Study Group. Lancet 1998; 352:837-53. Erratum in: Lancet 1999; 354:602.
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. UK Prospective Diabetes Study Group. Lancet 1998; 352:837-53. Erratum in: Lancet 1999; 354:602.
6. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317:703-13.
7. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997; 127:788-95.
8. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351:1755-62.
9. Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 2003; 138:593-602.
10. Ministry of Health of Malaysia. Clinical practice guidelines on the management of hypertension 2002. Malaysia: Ministry of Health, 2002.
11. Melaka Tengah district health office, Ministry of Health of Malaysia. Diabetic registry for Melaka Tengah district 2003. Malaysia: Ministry of Health, 2003.
12. Mustaffa BE, Mohamad WB, Chan SP, Rokiah P, Mafauzy M, Kumari S, et al. The current status of diabetes management in Malaysia. JAFES 1998; 16:1-13.
13. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: data from the Health Examination Survey, 1960-1991. Hypertension 1995; 155:1855-60.
14. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Eng J Med 2001; 345:479-86.
15. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, et al. Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36:646-61.
16. Psaty BM, Furberg CD, Kuller LH, Cushman M, Savage PJ, Levine D, et al. The association between level of blood pressure and the risk of myocardial infarction, stroke and total mortality: the Cardiovascular Health Study. Arch Intern Med 2001; 161:1183-92.
17. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 2002; 288:2981-97.
18. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861-9.
19. Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Cavazzini C, et al. Health outcomes associated with calcium antagonist compared with other first-line antihypertensive therapies: a meta-analysis of randomized controlled trials. Lancet 2000; 356:1949-54.
20. Moser M. Is it time for a new approach to the initial treatment of hypertension? Arch Intern Med 2001; 161:1140-4.
21. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendation for a call to action: a statement for healthcare professionals. Circulation 1997; 95:1085-90.
22. Elliott WJ, Maddy R, Toto R, Bakris G. Hypertension in patients with diabetes: overcoming barriers to effective control. Postgrad Med 2000; 107:29-38.
23. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282:1458-65.
24. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GL, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162:413-20.
25. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Eng J Med 1998; 339:1957-63.